Senate Health Democrats Press FDA’s Crawford For Plan B Decision Timeline
This article was originally published in The Pink Sheet Daily
Executive Summary
Senate Health Committee Democrats are asking to meet with FDA Commissioner nominee Lester Crawford to discuss the Rx-to-OTC switch of Barr's emergency contraceptive Plan B prior to voting on his nomination
You may also be interested in...
FDA's Crawford Open To Discussing Independent Drug Safety Office
Acting Commissioner Crawford tells members of the Senate Health Committee during his confirmation hearing that he is willing to talk about a more independent safety review office. However, the commissioner nominee also says the Office of Drug Safety already is "operating independently."
FDA's Crawford Open To Discussing Independent Drug Safety Office
Acting Commissioner Crawford tells members of the Senate Health Committee during his confirmation hearing that he is willing to talk about a more independent safety review office. However, the commissioner nominee also says the Office of Drug Safety already is "operating independently."
FDA’s Morning After The Inauguration: No Plan B Decision
The agency was unable to reach a decision on Barr’s application for an OTC switch of the emergency contraceptive by the Jan. 21 user fee date; Barr expects a decision from FDA “in the near future.”